[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Thermo Fisher Scientific (TMO)

Thermo Fisher Scientific (TMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

Is Quest Diagnostics Stock Underperforming the S&P 500?

With a market cap of $21.9 billion, Quest Diagnostics Incorporated (DGX) is a leading provider of diagnostic testing services in the United States and internationally. The company operates through two primary business groups - Diagnostic Information Services and Diagnostic Solutions, serving a wide range of clients including physicians, hospitals, insurers, and government agencies. 

Companies valued at $10 billion or more are generally classified as “large-cap” stocks, and Quest Diagnostics fits this criterion perfectly, exceeding the mark. Quest focuses on accelerating growth through strategic partnerships and innovation, while driving operational excellence across its customer value chain and IT infrastructure.

Fundamentals

See More
  • Market Capitalization, $K 172,658,816
  • Shares Outstanding, K 371,621
  • Annual Sales, $ 44,556 M
  • Annual Income, $ 6,704 M
  • EBIT $ 7,894 M
  • EBITDA $ 10,674 M
  • 60-Month Beta 0.88
  • Price/Sales 3.85
  • Price/Cash Flow 15.28
  • Price/Book 3.32

Options Overview Details

View History
  • Implied Volatility 31.61% (+0.28%)
  • Historical Volatility 33.88%
  • IV Percentile 60%
  • IV Rank 55.94%
  • IV High 39.64% on 10/16/25
  • IV Low 21.43% on 11/12/25
  • Expected Move (DTE 6) 14.98 (3.22%)
  • Put/Call Vol Ratio 0.55
  • Today's Volume 3,126
  • Volume Avg (30-Day) 3,359
  • Put/Call OI Ratio 0.93
  • Today's Open Interest 61,412
  • Open Int (30-Day) 59,762
  • Expected Range 449.63 to 479.59

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 25 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $5.74
  • Number of Estimates 10
  • High Estimate $6.00
  • Low Estimate $5.65
  • Prior Year $5.36
  • Growth Rate Est. (year over year) +7.09%

Price Performance

See More
Period Period Low Period High Performance
1-Month
438.66 +5.92%
on 05/20/26
499.00 -6.89%
on 05/29/26
+22.61 (+5.12%)
since 05/18/26
3-Month
435.27 +6.74%
on 05/18/26
538.41 -13.71%
on 04/21/26
-0.08 (-0.02%)
since 03/18/26
52-Week
390.50 +18.98%
on 06/20/25
643.99 -27.85%
on 01/22/26
+72.05 (+18.35%)
since 06/18/25

Most Recent Stories

More News
Is Quest Diagnostics Stock Underperforming the S&P 500?

While Quest Diagnostics has lagged behind the S&P 500 Index over the past year, analysts are moderately optimistic about the stock’s prospects.

DGX : 195.00 (-1.40%)
$SPX : 7,500.58 (unch)
TMO : 464.61 (+0.63%)
3 Reasons TMO is Risky and 1 Stock to Buy Instead

3 Reasons TMO is Risky and 1 Stock to Buy Instead

TMO : 464.61 (+0.63%)
Is Mettler-Toledo Stock Underperforming the S&P 500?

Although Mettler-Toledo has lagged behind the S&P 500 Index over the past year, analysts are moderately optimistic about the stock’s prospects.

$SPX : 7,500.58 (unch)
TMO : 464.61 (+0.63%)
MTD : 1,144.84 (+1.36%)
Is Agilent Technologies Stock Outperforming the Nasdaq?

Agilent Technologies has outperformed the Nasdaq recently, and analysts remain highly optimistic about the stock’s prospects.

A : 127.06 (+2.20%)
$NASX : 26,517.93 (unch)
TMO : 464.61 (+0.63%)
2 of Wall Street’s Favorite Stocks with Exciting Potential and 1 Facing Challenges

2 of Wall Street’s Favorite Stocks with Exciting Potential and 1 Facing Challenges

DY : 456.65 (-1.03%)
TMO : 464.61 (+0.63%)
CR : 214.90 (+2.75%)
Is Thermo Fisher Scientific Stock Underperforming the S&P 500?

Despite Thermo Fisher Scientific's underperformance relative to the SPX over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.

$SPX : 7,500.58 (unch)
TMO : 464.61 (+0.63%)
DHR : 177.17 (-0.33%)
3 Cash-Producing Stocks We Steer Clear Of

3 Cash-Producing Stocks We Steer Clear Of

TMO : 464.61 (+0.63%)
CRMT : 2.40 (+8.60%)
AGYS : 87.51 (-0.17%)
Thermo Fisher Scientific Unveils Next-generation Innovations at ASMS 2026 to Accelerate the Path from Drug Discovery to New Therapies

New mass spectrometry platforms, combined with AI-driven analytics and scalable proteomics solutions, help scientists turn complex biology into actionable insights across research and drug development

TMO : 464.61 (+0.63%)
Thermo Fisher Scientific Announces Quarterly Dividend

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0.47 per common share, payable on July...

TMO : 464.61 (+0.63%)
Thermo Fisher Scientific Highlights Industry Leadership, Growth Outlook and Long-Term Value Creation at 2026 Investor Day

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, hosted its Investor Day today. Chairman and Chief Executive Officer Marc N. Casper and members of the senior leadership team...

TMO : 464.61 (+0.63%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies...

See More

Key Turning Points

3rd Resistance Point 477.64
2nd Resistance Point 472.79
1st Resistance Point 468.70
Last Price 464.61
1st Support Level 459.76
2nd Support Level 454.91
3rd Support Level 450.82

See More

52-Week High 643.99
Fibonacci 61.8% 547.16
Fibonacci 50% 517.24
Fibonacci 38.2% 487.33
Last Price 464.61
52-Week Low 390.50

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.